Rotavirus infections are responsible for acute winter viral gastroenteritis. Two vaccines (Rotarix and RotaTeq), administered orally, have marketing authorization in France.
Article written by
Posted
Update
Reading time : 1 min.
The objective is to prevent serious forms and hospitalizations. The High Authority for Health (HAS) recommended, on Tuesday July 12, after reassessment of the vaccines, to resume vaccinating infants from six weeks to six months against rotavirus infections. These are the main culprits of acute winter viral gastroenteritis.
Two vaccines (Rotarix and RotaTeq), administered orally, have marketing authorization in France. Vaccination is recommended with two doses at the ages of two and three months for Rotarix, with three doses at two, three and four months for RotaTeq, specifies the HAS. It recommends using the same vaccine for the entire vaccination schedule.
The HAS insists on respecting this schedule in order to be able to complete the vaccination schedule before the age limit (six months for Rotarix and eight months for RotaTeq). “At this stage, the HAS considers that it is premature to consider making this vaccination compulsory”, she says. Recommended by the World Health Organization, the European Academy of Pediatrics and the European Society for Pediatric Infectious Diseases, vaccination against rotavirus infections is practiced in 127 countries.